LOAMU
PVLA

Lombard Odier Asset Management (USA)’s Palvella Therapeutics PVLA Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,750
Closed -$930K – 313
2020
Q2 		$930K Hold
3,750
– – 0.06% 184
2020
Q1 		$684K Sell
3,750
-1,250
-25% -$315K 0.07% 155
2019
Q4 		$1.45M Sell
5,000
-716
-13% -$199K 0.13% 159
2019
Q3 		$1.56M Sell
5,716
-699
-11% -$271K 0.15% 155
2019
Q2 		$2.41M Hold
6,415
– – 0.19% 120
2019
Q1 		$1.72M Hold
6,415
– – 0.14% 146
2018
Q4 		$1.36M Buy
6,415
+1,340
+26% +$416K 0.11% 156
2018
Q3 		$2.27M Sell
5,075
-1,973
-28% -$857K 0.17% 150
2018
Q2 		$2.86M Buy
7,048
+625
+10% +$297K 0.19% 147
2018
Q1 		$3.5M Sell
6,423
-1,990
-24% -$1.23M 0.25% 105
2017
Q4 		$5.08M Hold
8,413
– – 0.39% 76
2017
Q3 		$3.88M Sell
8,413
-8,580
-50% -$3.66M 0.28% 99
2017
Q2 		$6.88M Sell
16,993
-14,257
-46% -$4.17M 0.54% 58
2017
Q1 		$6.5M Buy
31,250
+963
+3% +$170K 0.61% 49
2016
Q4 		$3.4M Sell
30,287
-9,299
-23% -$1.15M 0.43% 82
2016
Q3 		$5.79M Hold
39,586
– – 0.54% 63
2016
Q2 		$5.1M Buy
39,586
+6,674
+20% +$1.02M 0.62% 55
2016
Q1 		$5M Sell
32,912
-2,698
-8% -$380K 0.68% 56
2015
Q4 		$6.52M Buy
35,610
+1,425
+4% +$239K 0.63% 65
2015
Q3 		$5M Buy
34,185
+1,799
+6% +$401K 0.44% 83
2015
Q2 		$7.13M Buy
+32,386
New +$7.12M 0.51% 55

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s PVLA Position: Q3 2020 in Review

Lombard Odier Asset Management (USA) sold out of Palvella Therapeutics (PVLA) in Q3 2020, closing a stake of 3,750 shares — an estimated $930K sold.

Lombard Odier Asset Management (USA) first reported a position in PVLA in Q2 2015 and held it in 21 quarters. The position peaked at $7.13M in Q2 2015. 88 funds tracked by Wall St. Rank hold PVLA as of Q3 2020.

  • Lombard Odier Asset Management (USA) reported no remaining Palvella Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 3,750 Palvella Therapeutics shares in Q3 2020, an estimated $930K.
  • Lombard Odier Asset Management (USA) first reported a position in Palvella Therapeutics in Q2 2015 and held it in 21 quarters.
  • Lombard Odier Asset Management (USA)'s Palvella Therapeutics position peaked at $7.13M in Q2 2015.
  • 88 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2020.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2020, filed 16 Nov 2020.